Accreditation The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: The American Medical Directors Association designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AMDCP Credit Designation: This session has been approved for a total of 1.5 Clinical credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
Session Description: This session will discuss a systematic approach to reducing adverse polypharmacy. Educational strategies will include a short didactic review of the principles of polypharmacy reduction. Attendees will then have opportunities to apply these principles in small group discussions of clinical cases. Each group will report on their findings. Small group discussion will also be used to elicit participant perceptions of barriers to implementing polypharmacy reduction programs in facilities. The entire group will reconvene to synthesize and summarize ideas. Due to reliance on small group format, attendance is limited to 80 participants.
Review principles of polypharmacy reduction.
Apply these principles to clinical cases.
Examine strategies for implementing polypharmacy reduction programs in long-term care practice.
Speakers(s): Daniel Bluestein, MD, MS, CMD; Thomas J. Lynch, PharmD; William N. Hovland, MD, CMD
Disclosure(s): Daniel Bluestein, MD, MS, CMD has no financial disclosures to report. William N. Hovland, MD, CMD has no financial disclosures to report. Thomas J. Lynch, PharmD has no financial disclosures to report.